Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018356 · ClinicalTrials.gov registry record · Phase 4
Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly
A Phase 4 study of Muscle Weakness and Muscular Atrophy, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT00018356 is a Phase 4 study of Muscle Weakness and Muscular Atrophy that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 88 participants, above the 71-participant average among 25 other Muscle Weakness trials with a reported enrollment target (24% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00018356, a Phase 4 study of Muscle Weakness and Muscular Atrophy, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
This study's primary objective is to determine the independent and combined effects of progressive resistance muscle strength training and testosterone on the development of sustainable improvements in physical function.
Conditions Studied
Interventions
- DRUG testosterone
- PROCEDURE exercise
Study Locations (1)
Arkansas
- Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock - No. Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 1999-01 |
| Est. Completion | 2006-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00018356
The ClinicalTrials.gov registry entry for NCT00018356 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 71-participant average among 25 other Muscle Weakness trials with a reported enrollment target (24% higher). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Muscle Weakness appearing as the primary indexed condition, and to 2 interventions - of which testosterone is the first listed.
NCT00018356 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT00018356 about?
NCT00018356 is a clinical study titled "Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly". This study's primary objective is to determine the independent and combined effects of progressive resistance muscle strength training and testosterone on the development of sustainable improvements in physical function.
What is the current status of trial NCT00018356?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 88 participants. The study started on 1999-01. Estimated completion is 2006-08.
What conditions does trial NCT00018356 study?
This clinical trial studies the following conditions: Muscle Weakness, Muscular Atrophy.
What interventions are being tested in trial NCT00018356?
The interventions under investigation include: testosterone (DRUG), exercise (PROCEDURE).
Who is sponsoring clinical trial NCT00018356?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00018356 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle Weakness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Depo-Medrol on Psoas After LLIF
RECRUITING · Phase 4
-
Best Practice Using Rocuronium and Reversal With Neostigmine or Sugammadex
COMPLETED · Phase 4
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults
RECRUITING
-
FIT Exercise in 30d of ULLS-induced Muscle Disuse
RECRUITING · NA
-
Muscle Recovery After Critical Illness
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.